Cramer's lightning round: Enbridge is a buy - 09 iunie 2022: Diferență între versiuni

Versiunea curentă din 18 mai 2023 15:01

Blackline Inc (US.BL): “They’re losing money. ... We can just not go with it.

Enbridge Inc (US.ENB): “That is exactly what you should be buying.”

AxoGen Inc (US.AXGN): “It’s a medical device, and I think you have to stick with tried and true. .. Johnson & Johnson.”

MetLife Inc (US.MET): “I’m going to have to say yes to that, even as I’m not a great fan of the insurers. ... That is too cheap a stock.”

Bridge Investment Group Holdings: “We don’t really know what they do. ... Pass, because there’s too much room for error.”

Farfetch Ltd (US.FTCH): “I say, buy Target down here.”

https://www.cnbc.com/2022/06/07/cramers-lightning-round-enbridge-is-a-buy.html

@@ Linia 1: / Linia 1: @@
-<p style="text-align: justify; "><br/></p><p style="text-align: justify; ">Blackline Inc (US.BL): “They’re losing money. ... We can just not go with it. </p><p style="text-align: justify; ">[[Enbridge Inc]] (US.ENB): “That is exactly what you should be buying.”</p><p style="text-align: justify; ">[[AXOGEN INC|AxoGen Inc]] (US.AXGN): “It’s a medical device, and I think you have to stick with tried and true. .. Johnson &amp; Johnson.” </p><p style="text-align: justify; ">[[Metlife Inc|MetLife Inc]] (US.MET): “I’m going to have to say yes to that, even as I’m not a great fan of the insurers. ... That is too cheap a stock.” </p><p style="text-align: justify; ">Bridge Investment Group Holdings: “We don’t really know what they do. ... Pass, because there’s too much room for error.” </p><p style="text-align: justify; ">Farfetch Ltd (US.FTCH): “I say, buy Target down here.”</p><p style="text-align: justify; "><br/></p><p style="text-align: justify; ">[https://www.cnbc.com/2022/06/07/cramers-lightning-round-enbridge-is-a-buy.html https://www.cnbc.com/2022/06/07/cramers-lightning-round-enbridge-is-a-buy.html]<br/></p>
+<p style="text-align: justify; "><br/></p><p style="text-align: justify; ">Blackline Inc (US.BL): “They’re losing money. ... We can just not go with it. </p><p style="text-align: justify; ">Enbridge Inc (US.ENB): “That is exactly what you should be buying.”</p><p style="text-align: justify; ">AxoGen Inc (US.AXGN): “It’s a medical device, and I think you have to stick with tried and true. .. Johnson &amp; Johnson.” </p><p style="text-align: justify; ">MetLife Inc (US.MET): “I’m going to have to say yes to that, even as I’m not a great fan of the insurers. ... That is too cheap a stock.” </p><p style="text-align: justify; ">Bridge Investment Group Holdings: “We don’t really know what they do. ... Pass, because there’s too much room for error.” </p><p style="text-align: justify; ">Farfetch Ltd (US.FTCH): “I say, buy Target down here.”</p><p style="text-align: justify; "><br/></p><p style="text-align: justify; ">[https://www.cnbc.com/2022/06/07/cramers-lightning-round-enbridge-is-a-buy.html https://www.cnbc.com/2022/06/07/cramers-lightning-round-enbridge-is-a-buy.html]<br/></p>
 [[Categorie:US.AXGN]][[Categorie:US.BL]][[Categorie:US.ENB]][[Categorie:US.FTCH]][[Categorie:US.MET]][[Categorie:Analize]][[Categorie:Stiri despre piata]]
 {{DEFAULTSORT:-2022-06-09}}